DailyUpdates for R&D News
LeadDiscovery constantly monitors the websites of Pharmaceutical and Biotech companies. Press releases relating to drug development activity are featured on DailyUpdates providing timely alerts to new clinical data, pipeline advances and regulatory news. Press releases are linked to their original source.
Latest News
- Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation for the Crofelemer NDA for Treatment of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy
- Novel Drug Shows Significant Promise in Treating Severe Stroke Patients
- Chimerix Antiviral Compound CMX001 Meets CMV Phase 2 Primary Endpoint in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- NanoViricides Inc. Submits Pre-IND Briefing Document for its Anti-Influenza drug, FluCide™, to the US FDA
- Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia
- Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar
- Anacor Pharmaceuticals Announces Positive Preliminary Results from Two Safety Studies of AN2728 and Updates Atopic Dermatitis Results and Regulatory Status
- Merck and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302
- FDA Grants Genentech\'s Pertuzumab Priority Review for Previously Untreated HER2-Positive Metastatic Breast Cancer
- EpiCept Files for AmiKet™ Fast Track Designation
- New Study Evaluates Cialis® in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
- Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Adults with ADHD